Media contacts
 |
Tatyana Albaut PR Director Phone: +7 495 230 02 90 |
Send message:
Shareholders
Pipeline
Media Center
-
Anti-cancer drugs are supplied to Russia without disruptions
06 February 2023
-
Russia’s government will allow import of unregistered biomedical cellular products
06 February 2023
-
Cell therapy biotech shifts focus to UK, makes deep cuts to US headcount
03 February 2023
-
Murashko: “The situation with the production of pharmaceutical substances for antibiotics is stable”
03 February 2023